Erinn Downs‐Kelly - Concepedia

Author

Erinn Downs‐Kelly

Also Known As

Downs-Kelly, Erinn, E DOWNSKELLY, E Downs-Kelly, E. DOWNS-KELLY, E. Downs-Kelly, E. Downs‐Kelly, E. P. Downs-Kelly, Erinn Downs-Kelly, Erinn Downs‐Kelly, Erinn P. Downs-Kelly

130

Publications

Citations

H-Index

118

Concepts

All Affiliations

Cleveland Clinic University of Utah Cleveland Clinic Lerner College of Medicine Huntsman Cancer Institute Case Western Reserve University

About

Erinn Downs‐Kelly is an author at Cleveland Clinic specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	39	3.3K
2	Health Sciences	5	5	193
3	Engineering	4	4	400
4	Allergy	2	2	72
5	Natural Sciences	1	1	92

Erinn Downs‐Kelly

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells Robert B. West, Brian P. Rubin, Melinda A. Miller, Proceedings of the National Academy of Sciences Tumoral PathologyTenosynovial Giant-cell TumorMalignant DiseaseMedicineImmunology	2006	547
TLE1 as a Diagnostic Immunohistochemical Marker for Synovial Sarcoma Emerging From Gene Expression Profiling Studies Jefferson Terry, Tsuyoshi Saito, Subbaya Subramanian, The American Journal of Surgical Pathology T-regulatory CellImmunologyImmunoeditingPathologyImmunotherapy	2007	345
Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene Fredrik Mertens, Christopher D.�M. Fletcher, Cristina R. Antonescu, Laboratory Investigation	2005	314
Fluorescence in situ hybridization for MDM2 gene amplification as a diagnostic tool in lipomatous neoplasms Joshua Weaver, Erinn Downs‐Kelly, John R. Goldblum, Modern Pathology Tumor BiologyEngineeringNovel Imaging MethodMedicineMolecular Pathology	2008	268
Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer Alice Tzeng, Naseer Sangwan, Margaret Jia, Genome Medicine	2021	253
Poor Interobserver Agreement in the Distinction of High-Grade Dysplasia and Adenocarcinoma in Pretreatment Barrett's Esophagus Biopsies Erinn Downs‐Kelly, Joel E. Mendelin, Ana E. Bennett, The American Journal of Gastroenterology	2008	182
Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes Andres Forero, Yufeng Li, Dongquan Chen, Cancer Immunology Research Breast OncologyImmunologyPathologyAntigen ProcessingImmunotherapeutics	2016	161
The Utility of Fluorescence In Situ Hybridization (FISH) in the Diagnosis of Myxoid Soft Tissue Neoplasms Erinn Downs‐Kelly, John R. Goldblum, Rajiv M. Patel, The American Journal of Surgical Pathology Myxoid LiposarcomaFus ProbesTumoral PathologyTumor HeterogeneityMedicine	2008	123
The Influence of Polysomy 17 on HER2 Gene and Protein Expression in Adenocarcinoma of the Breast Erinn Downs‐Kelly, Brian J. Yoder, Mark H. Stoler, The American Journal of Surgical Pathology Breast OncologyPolysomy 17PathologyCancer BiologyTumor Biology	2005	122
Genome‐wide transcriptome analyses reveal p53 inactivation mediated loss of miR‐34a expression in malignant peripheral nerve sheath tumours Subbaya Subramanian, Venugopal Thayanithy, Robert B. West, The Journal of Pathology	2009	120

Page 1